4.52
Schlusskurs vom Vortag:
$4.58
Offen:
$4.6
24-Stunden-Volumen:
27,949
Relative Volume:
0.01
Marktkapitalisierung:
$4.30M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-16.72M
KGV:
-0.0706
EPS:
-64.0349
Netto-Cashflow:
$-12.29M
1W Leistung:
-1.56%
1M Leistung:
-55.88%
6M Leistung:
-51.37%
1J Leistung:
-82.27%
Autonomix Medical Inc Stock (AMIX) Company Profile
Firmenname
Autonomix Medical Inc
Sektor
Branche
Telefon
832-277-7816
Adresse
21 WATERWAY AVENUE, SUITE 300, THE WOODLANDS
Compare AMIX vs ABT, MDT, SYK, BSX, EW
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
|
AMIX
Autonomix Medical Inc
|
4.43 | 4.45M | 0 | -16.72M | -12.29M | -64.03 |
|
ABT
Abbott Laboratories
|
106.03 | 182.59B | 46.59B | 5.41B | 7.38B | 3.0938 |
|
MDT
Medtronic Plc
|
92.80 | 118.18B | 36.36B | 4.84B | 5.43B | 3.7261 |
|
SYK
Stryker Corp
|
273.31 | 106.03B | 25.27B | 3.34B | 4.57B | 8.6334 |
|
BSX
Boston Scientific Corp
|
45.67 | 65.19B | 20.62B | 3.56B | 3.48B | 2.3847 |
|
EW
Edwards Lifesciences Corp
|
86.39 | 49.99B | 6.30B | 1.07B | 1.09B | 1.8406 |
Autonomix Medical Inc Aktie (AMIX) Neueste Nachrichten
Autonomix Medical stock halts, surges 116% on preclinical data - scanx.trade
Reverse split vote looms for Autonomix Medical (AMIX) - stocktitan.net
AMIX Stock Quote Price and Forecast - CNN
Autonomix Medical Announces Acceptance of Two Abstracts for Poster Presentation at CIRSE 2026 - The Manila Times
Two abstracts on pain and nerve mapping earn poster slots in Copenhagen - Stock Titan
Autonomix Medical Raises $4.9 Million via Warrant Exercise, Issues New Five-Year Warrants - TradingView
Autonomix Medical Shares More Than Double After Hours on $4.9 Million Warrant Exercise Deal - finance.biggo.com
Autonomix Medical enters into warrant inducement agreement - Medical Buyer
Autonomix Medical Shares Surge Pre-Bell After $4.9 Million Warrant Inducement Priced at Premium to Market - marketscreener.com
Best Medical Stocks Worth WatchingAugust 25th - MarketBeat
Trending Stocks Today | Autonomix Medical Soars 138.64% Post-Market - Moomoo
Autonomix (AMIX) Levels: Records a Muted Move to $5.27 in the Latest Reading; Trading Range - vinanet.vn
Autonomix Medical secures U.S. patent for precision nerve sensing and cancer pain therapy - scanx.trade
Autonomix (AMIX) Momentum: Moves 10.83% Down to $5.27 in the Latest Reading; Trading Range: $5.01 and $5.53 Define the Nearby Reference Levels in the Current UpdateVolume Gap - vinanet.vn
Autonomix Medical enters $2.6 million warrant inducement agreement - scanx.trade
Autonomix (AMIX) Earnings Reading: Profit Per Share Surpasses Its Benchmark at the Close; Share Response: The Stock Records a 4.21% Decrease in Latest TradingEPS Surprise History - vinanet.vn
Autonomix (AMIX) Quarterly Results: EPS Prints Above Forecast; After Earnings: Shares Fall 3.40% in the Current UpdateReturn On Assets - dars.gov.et
Autonomix (AMIX) Quarterly Update: EPS Lands Above Forecast in the Current Update; Price Reaction: Shares Finish 5.86% Down in the Latest SessionFinancial Health Score - dars.gov.et
Autonomix Medical completes pre-clinical study for FDA submission By Investing.com - Investing.com Nigeria
Autonomix Medical (AMIX) Holds at $6.85 as Narrow Trading Range Defines Near-Term OutlookETF Creation Redemption - vinanet.vn
Price to sales forward of Autonomix Medical, Inc. – NASDAQ:AMIX - TradingView
Autonomix Medical, Inc. Reports Earnings Results for the First Quarter Ended June 30, 2026 - marketscreener.com
Autonomix Medical Q1 Results: EPS of $(5.02) beats estimate - scanx.trade
Autonomix Medical (AMIX) flags going-concern risk and $25–$30M funding need - Stock Titan
Autonomix Medical, Inc. (AMIX) Stock Price, News, Quote & History - Yahoo! Finance Canada
Autonomix Medical Stock Short Interest Rises to 50.21% - Moomoo
Autonomix Medical completes pre-clinical study for FDA submission - Investing.com
Autonomix Medical Completes Good Laboratory Practice (GLP) Preclinical Study, Marking Key Step Toward FDA Submission - The Manila Times
Autonomix Medical Completes GLP Pre-Clinical Study, Advancing FDA Submission - Quiver Quantitative
Autonomix CMO Robert Schwartz receives lifetime award - Investing.com
Autonomix CMO Robert Schwartz receives cardiovascular award By Investing.com - Investing.com Australia
Autonomix CMO Robert Schwartz receives lifetime award By Investing.com - Investing.com South Africa
Autonomix CMO Robert Schwartz receives cardiovascular award - Investing.com
Autonomix Medical Congratulates Co-Founder & Chief Medical Officer Dr. Robert Schwartz on Receiving Prestigious 2026 Cardiovascular Tech Forum Lifetime Achievement Award - The Manila Times
Autonomix Medical Congratulates Chief Medical Officer Robert Schwartz on 2026 CTF Lifetime Achievement Award - Quiver Quantitative
Autonomix Medical Congratulates Co-Founder & Chief Medical - GlobeNewswire
Why Autonomix Medical (AMIX) Stock Is Down Today - Quiver Quantitative
AMIX Stock Rockets On Resale News As Dilution Risks Build - StocksToTrade
12 Health Care Stocks Moving In Wednesday's Pre-Market Session - Benzinga
AMIX Stock Rockets As Cash Deals Collide With Dilution Fears - StocksToTrade
Autonomix Medical Soars 434% as Patent Filings Indicate 2025 GrantThe Wall Street Journal - TechStock²
Autonomix Medical, Inc. SEC Filing (Aug 5, 2026) - Stock Titan
SPCX, AMD, NVDA, ALAB, AMIX: 5 Trending Stocks TodayAdvanced Micro Devices (NASDAQ:AMD) - Benzinga
Autonomix Medical receives patent for nerve-targeting cancer tech By Investing.com - Investing.com UK
$Autonomix Medical (AMIX.US)$ On at 17.31 sold shares at esch level above entry, holding runners - Moomoo
Autonomix Stock Skyrockets After Obtaining Key Cancer Tech Patent - benzinga.com
12 Health Care Stocks Moving In Tuesday's Intraday Session - Benzinga
Why Autonomix Medical Stock Has More Than Doubled Today - AskTraders
Autonomix Medical Receives U.S. Patent for Precision Neuromodulation Platform Expansion - Yahoo Finance
Why is Autonomix Medical stock surging today? By Investing.com - Investing.com India
Finanzdaten der Autonomix Medical Inc-Aktie (AMIX)
Umsatz
Nettogewinn
Free Cashflow
ENV
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):